One microliter of the inoculant (PBS as control or virus solution containing 104 genome equivalents of IAPV) was injected using a NanoJet™ syringe pump (Chemix, USA) with an infusion flow rate of 0.1µl/sec, following manufacturer’s parameters. The needle was inserted in the lateral abdomen between the fourth and fifth tergite of young, white-eye honey bee pupae (
Two strong, IAPV-free hives were selected from the UNCG research apiary, representing two distinct sources of bees for the experiment. From each hive, 200 white-eye pupae were collected for each of the following treatment groups: without inoculation (W/O), PBS inoculated (PBS), and IAPV inoculated (IAPV). From each treatment group and hive, 50 bees were frozen at 0 h, 5 h, 20 h and 48 h after inoculation and a subset of these samples was individually analyzed for viral titers and gene expression patterns. The first time point directly after inoculation was used as a control of the initial states of the bees in the experimental and control groups. The time point of five hours post-infection was chosen to measure the virus impact before completion of the replication cycle, based on the assumption that IAPV follows the picornavirus family average timing for a replication cycle, of 7–12 hours [32] , [34] (link), [35] (link). Any gene expression changes at this time point represent the bees’ response to inoculation without complications from virus-related tissue damage. The time point of 20 h post-infection was considered representative of events after one complete cycle of virus replication, and the 48 h time point represents the established diseased state, characterized by visual symptoms.
Based on the results of the preliminary experiments (